Injections, Intralesional

"Injections, Intralesional" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Injections introduced directly into localized lesions.

Descriptor ID	D015552
MeSH Number(s)	E02.319.267.530.430
Concept/Terms	Injections, Intralesional Injections, Intralesional Intralesional Injections Injection, Intralesional Intralesional Injection

Below are MeSH descriptors whose meaning is more general than "Injections, Intralesional".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Injections [E02.319.267.530]
Injections, Intralesional [E02.319.267.530.430]

Below are MeSH descriptors whose meaning is related to "Injections, Intralesional".

Below are MeSH descriptors whose meaning is more specific than "Injections, Intralesional".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Injections, Intralesional" by people in this website by year, and whether "Injections, Intralesional" was a major or minor topic of these publications.

Bar chart showing 12 publications over 7 distinct years, with a maximum of 3 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2001	0	1	1
2006	0	2	2
2007	0	1	1
2009	0	2	2
2012	0	1	1
2016	1	2	3
2020	0	2	2

Below are the most recent publications written about "Injections, Intralesional" by people in Profiles.

Haines BB, Denslow A, Grzesik P, Lee JS, Farkaly T, Hewett J, Wambua D, Kong L, Behera P, Jacques J, Goshert C, Ball M, Colthart A, Finer MH, Hayes MW, Feau S, Kennedy EM, Lerner L, Qu?va C. ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity. Cancer Immunol Res. 2021 03; 9(3):291-308.

View in: PubMed
?zcan D, Se?kin D, Kibaroglu S, Bernhard JD. Intralesional triamcinolone acetonide in notalgia paresthetica: Treatment outcomes in five patients. Dermatol Ther. 2020 07; 33(4):e13462.

View in: PubMed
Albertini MR, Ranheim EA, Zuleger CL, Sondel PM, Hank JA, Bridges A, Newton MA, McFarland T, Collins J, Clements E, Henry MB, Neuman HB, Weber S, Whalen G, Galili U. Phase I study to evaluate toxicity and feasibility of intratumoral injection of a-gal glycolipids in patients with advanced melanoma. Cancer Immunol Immunother. 2016 08; 65(8):897-907.

View in: PubMed
Muthusamy VR, Chandrasekhara V, Acosta RD, Bruining DH, Chathadi KV, Eloubeidi MA, Faulx AL, Fonkalsrud L, Gurudu SR, Khashab MA, Kothari S, Lightdale JR, Pasha SF, Saltzman JR, Shaukat A, Wang A, Yang J, Cash BD, DeWitt JM. The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms. Gastrointest Endosc. 2016 Jul; 84(1):1-9.

View in: PubMed
Clark A, Jellinek NJ. Intralesional Injection for Inflammatory Nail Diseases. Dermatol Surg. 2016 Feb; 42(2):257-60.

View in: PubMed
Rastogi N, Williams G, Alencar H. Modality-specific occult intrarenal pseudoaneurysm in a renal allograft and the legacy of catheter angiography. Ann Vasc Surg. 2013 Nov; 27(8):1184.e7-11.

View in: PubMed
Whalen GF, Sullivan M, Piperdi B, Wasseff W, Galili U. Cancer immunotherapy by intratumoral injection of a-gal glycolipids. Anticancer Res. 2012 Sep; 32(9):3861-8.

View in: PubMed
Rodriguez L, Rosen R, Manfredi M, Nurko S. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study. Gastrointest Endosc. 2012 Feb; 75(2):302-9.

View in: PubMed
Giuliari GP, Hinkle DM, Foster CS. Local treatment for lymphoid malignancies of the eye. Anticancer Agents Med Chem. 2009 Dec; 9(10):1123-8.

View in: PubMed
Yoo GH, Moon J, Leblanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J, Wolf G. A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group. Arch Otolaryngol Head Neck Surg. 2009 Sep; 135(9):869-74.

View in: PubMed

People

Explore

Similar Concepts

Top Journals